about
Prevalence of potential drug-drug interactions involving antiretroviral drugs in a large Kenyan cohortScreening by Clinical Breast Examination in Western Kenya: Who Comes?Collateral benefits arising from mass administration of azithromycin in the control of active trachoma in resource limited settingsA Review of the Ingredients Contained in Over the Counter (OTC) Cough Syrup Formulations in Kenya. Are They Harmful to Infants?Intracellular accumulation of Praziquantel in T lymphoblastoid cell lines, CEM (parental) and CEMVBL(P-gp-overexpressing).Palmar-plantar erythrodysesthesia associated with capecitabine chemotherapy: a case reportDrug-transporter mediated interactions between anthelminthic and antiretroviral drugs across the Caco-2 cell monolayers.A study of the medicinal plants used by the Marakwet Community in Kenya.Early neurosyphilis presenting with facial palsy and an oral ulcer in a patient who is human immunodeficiency virus positive: a case report.Reversal of tenofovir induced nephrotoxicity: case reports of two patients.Medicinal Plants Used by Traditional Healers in Sangurur, Elgeyo Marakwet County, Kenya.Factors associated with the high prevalence of oesophageal cancer in Western Kenya: a review.Randomized Phase IIA Trial of Gemcitabine Compared With Bleomycin Plus Vincristine for Treatment of Kaposi's Sarcoma in Patients on Combination Antiretroviral Therapy in Western KenyaCharacteristics of patients with thromboembolic disorders on warfarin therapy in resource limited settingsEnhancement of saquinavir absorption and accumulation through the formation of solid drug nanoparticlesEthnomedical Survey of the Plants Used by Traditional Healers in Narok County, KenyaThree year survival among patients with aids-related Kaposi sarcoma treated with chemotherapy and combination antiretroviral therapy at Moi teaching and referral hospital, Kenya
P50
Q28477246-18F0F272-A71D-4ACC-BDCC-BE4040CA0DB1Q33866101-075F7AE9-0E0F-4A58-A064-18CAF35CAB11Q35241395-34DC3181-B618-4274-9137-AF9D08902E73Q35833506-928F42B0-1DA4-4E9A-A314-8B2A02A54C07Q36103626-2D377B8D-ADB8-4D93-8479-27B93C470625Q36168362-4CC82E31-D427-459B-B080-EE1108A72A6BQ36362462-547BB840-EC25-45BD-951A-17CA602D99C9Q37681799-CB39F14E-105B-48B4-A8A6-CF8CFD0EAFA9Q40203467-E4D63E3C-41BF-432F-811F-49CD857D6E6EQ41495066-4F2D7A7C-DC25-4897-A31E-7322EFECDE8DQ47104590-BF2E70C7-E026-4B53-A1A2-26954AEB96F7Q47136146-E7261401-BA17-4136-8CCA-8653725CC627Q56909848-FE733DE7-9572-47CF-90DD-820E64415632Q58720888-2EC58E32-F039-407D-BC68-089458409BB8Q59793444-05A08FE6-BB95-4190-9FA4-C83BC90CCD57Q61808837-D0030A60-61CF-4C8A-A401-51F1559F4C76Q90087469-88A8417C-D5DB-4673-81A4-95C50366B296
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-5047-4066
@en
name
Gabriel Kigen
@ast
Gabriel Kigen
@en
Gabriel Kigen
@es
Gabriel Kigen
@nl
type
label
Gabriel Kigen
@ast
Gabriel Kigen
@en
Gabriel Kigen
@es
Gabriel Kigen
@nl
prefLabel
Gabriel Kigen
@ast
Gabriel Kigen
@en
Gabriel Kigen
@es
Gabriel Kigen
@nl
P106
P1153
40561338200
P21
P31
P496
0000-0002-5047-4066